Epigenetic reader domain inhibitor BET-IN-1, Purity ≥98%

Cat. No.: X24-05-ZQ422

Epigenetic reader domain inhibitor BET-IN-1, Purity ≥98%

Synonym: 1422554-34-4; BET-IN-1; I-BET282; CHEMBL4878439; (R)-4-(8-methoxy-1-(1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole; Epigenetic reader domain inhibitor

  • CAS Number: 1422554-34-4
  • Compound CID: 71258968
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BET-IN-1 disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
450.53
Molecular Formula
C25H30N4O4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BET-IN-1 can be used to investigate the inhibition of BET bromodomains and the consequent effects on gene transcriptional activity.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0